Kalydeco approved in U.S. for cystic fibrosis in patients aged 12 to < 24 months Aug. 16, 2018 No Comments
Alnylam's RNAi therapeutic Onpattro for polyneuropathy of hATTR amyloidosis receives first approval Aug. 13, 2018 No Comments
Petrovax Pharm's 4-valeant influenza vaccine --Grippol Quadrivalent-- approved in Russia Aug. 10, 2018 No Comments
RSS